Apollo Hospitals post 76% rise in Q4 profits to ₹254 crore

livemint.com:

₹253.8 crore for the quarter ended March, a 76% rise from the corresponding three months a year ago, buoyed by a continued reduction in losses at its pharmacy, health and lifestyle segments.During Q4, it reported revenues of ₹4,944 crore, a 15% y-o-y rise from ₹4,302.2 crore. The results were in line with Bloomberg analyst estimates.“The increase in PAT is not just attributable to the revenues but also significantly to the improving overall profitability of HealthCo, on which we have been working to break even quarter on quarter.

So clearly, it's a combination of growth as well as commitment towards profitability," Krishnan Akhileswaran, group chief financial officer, Apollo Hospitals, told Mint.Earnings before interest, tax, depreciation, and amortization (Ebitda) stood at ₹640 crore during Q4FY24, a 31% rise with a margin of 12.95%.“Going forward, Apollo Hospitals will continue to strengthen its endeavors to identify and introduce best-in-class, technology-enabled healthcare solutions to enhance patient outcomes and improve access to quality care," said Prathap C. Reddy, chairman, Apollo Hospitals Group, in a statement.The company, Akhileswaran said, will continue its growth momentum as Apollo plans to maintain its commitment to profitability in HealthCo, while volume growth in healthcare services remains strong.

HealthCo is Apollo’s digital healthcare and omni-channel pharmacy platform.The healthcare services segment reported an occupancy of 65% during Q4FY24, driven by a strong increase in patient flow across hospitals. It reported an increase in revenue of 17% to reach ₹2,562.6 crore during the quarter.The growth in healthcare services was driven by a strong penetration of insurance in the country, along with a